
Stroke Trials
@strokeclitrials
#StrokeTwitter
ID: 3016121269
10-02-2015 04:05:34
3,3K Tweet
11,11K Followers
252 Following

4/ Check out the full-length paper by Jim Siegler (@jimsieglermd.bsky.social now) Manisha Koneru, MD Shadi Yaghi @AlmuftiFawaz Tareq Kass-Hout Thanh Nguyen 🇺🇦 available OPEN ACCESS here: ahajournals.org/doi/10.1161/SV…

Hot off the heels of 3 paradigm shifting trial results of MMA embolization in cSDH, Michael Levitt, MD Josh Hirsch Michael Chen, MD review their results, impact, and upcoming future trials bit.ly/4bGT4AY #cSDH #mma


Now Online! 🗞️Variations in the prevalence of #atrial #fibrillation, and in the strength of its association with ischemic #stroke, in countries with different income levels: INTERSTROKE case–control study. journals.sagepub.com/doi/full/10.11… Robert Murphy

One of the very exciting stories in secondary prevention of stroke in recent years. Excited to see what more we learn from ARCADIA. Hooman Kamel jamanetwork.com/journals/jama/…


You can now read our latest paper JAMA Network Open The evidence from RCTs suggests that intensive post-EVT BP reduction does not yield benefits and may carry risks. Read more here: bit.ly/49K1RjL Mohamed Elfil, MD Hassan Kobeissi, M.D. Alzhraa Abbas, MD MayoNeurovascularLab


#LowerIsBetter 📉⬇️ Post-treatment level of LDL cholesterol and all-cause mortality in patients with atherosclerotic cardiovascular disease: evidence from real-world setting academic-oup-com.ezproxy.med.nyu.edu/eurjpc/article… Author Lay Summary 👉 “In this multicentre cohort comprising 33 968 patients at


#STROKE Topical Review by Bérenger Largeau et al: Posterior reversible encephalopathy syndrome #PRES: benefits and limitations of current experimental models aiming to study #PRES pathophysiology and develop new therapies. #AHAJournals ahajrnls.org/3uCWCDP Stephan Ehrmann



Just Accepted! 📰#Dabigatran etexilate versus #warfarin in cerebral venous #thrombosis in Chinese patients (CHOICE-CVT): an open-label, randomized controlled trial. journals.sagepub.com/doi/abs/10.117… Cambridge Stroke

Now Online! 🗞️Association between high-resolution magnetic resonance vessel wall imaging characteristics and recurrent #stroke in patients with intracranial atherosclerotic steno-occlusive disease: A prospective multicenter study. journals.sagepub.com/doi/abs/10.117… Cambridge Stroke


New sub-analysis of the SWIFT DIRECT Trial ➡️ #IVT in pts with anticipated emergent ICA stenting seemes safe: all❗️ pts w/ #tandem lesions achieved TICI2c-3 reperfusion; with no differences in mRS, mortality or sICH between EVT+IVT vs EVT-only groups. #GoLytics onlinelibrary.wiley.com/doi/full/10.11…


Just Accepted! 🗞️#Stroke and High-risk #TIAs Outcomes with Reduction of Treatment duration when treatment initiated in Emergency Rooms (SHORTER-Study). journals.sagepub.com/doi/abs/10.117… عادل الهزاني

Excited to be part of this American Heart Association scientific statement on #ArtificialIntelligence in #Cardiology with review, perils, pitfalls, and some thoughts on future directions👇 ahajournals.org/doi/epdf/10.11… Kayte Spector-Bagdady @drpaulfriedman Anne Kwitek EL Bijoy K Menon Katherine Sheehan, PhD ➡️


#STROKE March Cover Figure: Differential effects of tissue-type plasminogen activator (#tPA) originating from specific compartments during ischemic stroke thanks to #parabiosis in mice. #AHAJournals ahajrnls.org/49dbp7a @damien_levard Institut BB@C



Interested in learning more regarding predictors of hematoma expansion and response to andexanet alfa in patients with FXaI-associated ICH participating in the ANNEXa-I trial? I summarize our findings with NeurologyLive here: neurologylive.com/view/secondary… #neurotwitter McMaster University Department of Medicine

Don't miss this month's editorial! ✍️📜#Reperfusion therapy for #stroke: From improving global access, to #thrombectomy beyond 24 hours. journals.sagepub.com/doi/full/10.11… Cambridge Stroke
